PW Medtech Group Ltd. (HK:1358) has released an update.
PW Medtech Group Limited has announced a share repurchase plan under its Repurchase Mandate, with intentions to buy back shares worth up to HK$150 million, reflecting the company’s confidence in its long-term growth. The repurchase will be funded by the company’s available cash and will adhere to market conditions and regulatory guidelines. Shareholders are advised to exercise caution as the repurchase is subject to market conditions and board discretion.
For further insights into HK:1358 stock, check out TipRanks’ Stock Analysis page.
